4Bayraktar UD, Bashir Q, Qazilbash M, et al. Fifty years of melphalan use in hematopoietic stem cell transplantation [J]. Biol Blood Marrow Transplant, 2013,19(3) : 344. 被引量：1
5Phillips GL, Meisenberg B, Reece DE, et al. Amifostine and autologous hematopoietic stem cell support of escalat- ing-dose melphalan: a phase I study[J]. Biol Blood Mar- row Transplant, 2004,10 ( 7 ) : 473. 被引量：1
6Hersh MR, Ludden TM, Kuhn JG, et al. Pharmacokinetics of high dose melphalan[J]. Invest New Drugs, 1983,1 (4) : 331. 被引量：1
7Westerfield BT, Michalski JP, McCombs C, et al. Revers- ible melphalan-induced lung damage[J]. Am JMed, 1980, 68(5):767. 被引量：1
8Olivieri A, Corvatta L, Montanari M, et al. Paroxysmal atri- al fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells[J]. Bone Mar- row Transplant, 1998,21(10) : 1 049. 被引量：1
9Rajkumar SV. Treatment of multiple myeloma[J]. Nat Rev Clin 0ncol,2011,8(8) :479. 被引量：1
10Jagannath S, Vesole DH, Glenn L, et al. Low-risk inten- sive therapy for multiple myeloma with combined autolo- gous bone marrow and blood stem cell support[J]. Blood, 1992,80(7):1 666. 被引量：1
